Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00021866 · ClinicalTrials.gov registry record
Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 331
- Enrollment target
NCT00021866: Completed study, sponsored by Emory University.
NCT00021866 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 331 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00021866 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 331 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if antiepileptic drugs (AEDs) differ in their neurodevelopmental effects. Specifically, do the children of the women with epilepsy differ in their behavioral and cognitive development depending on which AED their mother takes during pregnancy?
Interventions
- BEHAVIORAL Neuropsychological Testing
- BEHAVIORAL Differential Abilities Scale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 331 participants |
| Start Date | 2000-09 |
| Est. Completion | 2012-08 |
What the finished NCT00021866 record still lists
NCT00021866 is an observational study that tracks outcomes without assigning an intervention. The registered 331 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Neuropsychological Testing is the first listed.
NCT00021866 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00021866 about?
NCT00021866 is a clinical study titled "Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy". The purpose of this study is to determine if antiepileptic drugs (AEDs) differ in their neurodevelopmental effects. Specifically, do the children of the women with epilepsy differ in their behavioral and cognitive development depending on which AED their mother takes during pregnancy?
What is the current status of trial NCT00021866?
This trial is currently completed. The enrollment target is 331 participants. The study started on 2000-09. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00021866?
The interventions under investigation include: Neuropsychological Testing (BEHAVIORAL), Differential Abilities Scale (BEHAVIORAL).
Who is sponsoring clinical trial NCT00021866?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174121 · 332 participants · Phase 2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- NCT02605785 · 332 participants · NA
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
- NCT04894006 · 332 participants · NA
Dementia Family Caregiver Study
- NCT05130606 · 332 participants · NA
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia